TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Pharmetheus AB
Closing information (x1000 EUR)
| Closing information | 2024/11 | 2023/11 | 2022/11 |
| Turnover |
16,554
|
16,778
|
13,711 |
| Financial expenses |
13
|
9
|
9 |
| Earnings before taxes |
1,365
|
4,307
|
3,523 |
| EBITDA |
1,407
|
4,354
|
3,573 |
| Total assets |
7,480
|
8,971
|
6,724 |
| Current assets |
5,947
|
8,689
|
6,602 |
| Current liabilities |
3,176
|
3,539
|
2,719 |
| Equity capital |
3,927
|
5,053
|
3,608 |
| - share capital |
5
|
6
|
6 |
| Employees (average) |
82
|
71
|
61 |
Financial ratios
| Fiscal year | 2024/11 | 2023/11 | 2022/11 |
| Solvency |
52.5%
|
56.3%
|
53.7% |
| Turnover per employee |
202
|
236
|
225 |
| Profit as a percentage of turnover |
8.2%
|
25.7%
|
25.7% |
| Return on assets (ROA) |
18.4%
|
48.1%
|
52.5% |
| Current ratio |
187.2%
|
245.5%
|
242.8% |
| Return on equity (ROE) |
34.8%
|
85.2%
|
97.6% |
| Change turnover |
-97
|
3,672
|
4,138 |
| Change turnover % |
-1%
|
28%
|
43% |
| Chg. No. of employees |
11
|
10
|
6 |
| Chg. No. of employees % |
15%
|
16%
|
11% |
Total value of public sale
| Fiscal year | 2024/11 | 2023/11 | 2022/11 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.